Xarelto

Filing a Xarelto Lawsuit

Take the Necessary Steps with The Pelham Law Firm

Xarelto was approved by the FDA in 2011 as a blood thinner. Manufactured by Bayer, Xarelto is prescribed to prevent blood clots, typically for patients who have undergone hip or knee replacements. In recent years, however, numerous lawsuits have been filed against Bayer for the serious side effects and injuries sustained by users throughout the country.

If you believe that you suffered as a result of taking Xarelto, you have come to the right place. Our personal injury lawyers have helped many victims recover deserved compensation and may be able to do the same for you.

Who Can File a Xarelto Lawsuit?

Through extensive research, thousands of serious health conditions have been linked to Xarelto. This has led victims to file lawsuits or join existing class action lawsuits to obtain compensation for their injuries. Xarelto lawsuits are based on several dangerous side effects, including:

  • Uncontrollable bleeding
  • Blood clots
  • Hemorrhaging
  • Sudden changes in blood pressure

In 2012, the FDA reported that three times more people died from complications of Xarelto compared to Warfarin, a similar blood-thinning medication. The side effects are not just painful – they can be fatal and Bayer should be held accountable for releasing such a dangerous drug. Lawsuits also seek to hold the manufacturer accountable for concealing necessary safety information from potential users.

Our Personal Injury Attorney Is on Your Side!

When your personal well-being has been compromised, the best thing you can do is consult with someone who is capable of executing justice on your behalf. That someone can be found at The Pelham Law Firm. Solely devoted to personal injury, we are well aware of the positive outcome you need and are prepared to work tirelessly to obtain it.

When you place your case in our hands, we won’t rest until it has been resolved in the best way possible. Today is the day to put an end to your suffering, so call our firm now.